1. The testosterone prescribing practice of BMS menopause specialists
   A Scott et al, 2021, Post Reproductive Health CrossRef
2. The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane
   Cristina Amaral et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
3. In Vitro Systematic Drug Testing Reveals Carboplatin, Paclitaxel, and Alpelisib as a Potential Novel Combination Treatment for Adult Granulosa Cell Tumors
   Joline Roze et al, 2021, Cancers CrossRef
4. Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development
   Abbie J. Laing et al, 2022, The Cancer Journal CrossRef
5. A proposal for the adsorption of anastrozole anticancer drug on gold nanoparticle surfaces
   Raïssa A.R. Teixeira et al, 2019, Journal of Raman Spectroscopy CrossRef
6. Differential biological effects of aromatase inhibitors: Apoptosis, autophagy, senescence and modulation of the hormonal status in breast cancer cells
   Tiago V. Augusto et al, 2021, Molecular and Cellular Endocrinology CrossRef
7. In Vitro Effects of Combining Genistein with Aromatase Inhibitors: Concerns Regarding Its Consumption during Breast Cancer Treatment
   Patrícia H. A. Bezerra et al, 2023, Molecules CrossRef
8. Androgen and breast cancer
   Keely M. McNamara et al, 2016, Current Opinion in Endocrinology, Diabetes & Obesity CrossRef
9. Synthesis and Anticancer Activity of Different 1,2,4-Triazolearyl Incorporated Thiazolepyridine Derivatives
   Sanivarapu Sumalatha et al, 2020, Russian Journal of General Chemistry CrossRef
10. Synthesis oftransN-Substituted Pyrrolidine Derivatives Bearing 1,2,4- triazole Ring
    Shaik Anwar et al, 2022, Current Organic Synthesis CrossRef